Reduces oxidative stress, promoting healthier aging and better immune function
Reduces hyperpigmentation and blemishes
doi: 10.1038/s44259-023-00016-1 [DOI] [PMC free article] [PubMed] [Google Scholar] 21.Belay WY, Getachew M, Tegegne BA, et al
Its refined composition is developed to support skin clarity, improve texture, and enhance overall skin smoothness
Lillys Zepbound, approved in November 2023 as the Indiana-based drug giants answer to Novo Nordisks Wegovy, showed 21% average weight loss after 72 weeks for its highest dose in its Phase 3 trial, and a mid-stage study of another Lilly experimental medicine, called retatrutide, showed 24% weight loss after just 48 weeks
Safety Considerations and When to Seek Provider Guidance Most injection-site burning is transient and resolves without intervention